Frazier Management LLC Iterum Therapeutics PLC Transaction History

Frazier Management LLC

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2021 Aug 11, 2021	SELL	$0.97 - $2.39 $1.49 Million - $3.68 Million	-1,538,316 Closed	0 $0
Q2 2018 Aug 15, 2018	BUY	$10.67 - $12.85 $16.4 Million - $19.8 Million	1,538,316 New	1,538,316 $16.4 Million

145

Ticker ITRM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 12,233,400
Market Cap $21.2M
Description
Iterum Therapeutics plc, a clinical-stage pharmaceutical company, engages in developing and commercializing anti-infectives in Ireland, Bermuda, and the United States. It is developing sulopenem, a novel anti-infective compound with oral and IV formulations that is in Phase III clinical trials for the treatment of uncomplicated urinary tract inf...

Get notified when there are updates to the investment portfolio of Frazier Management LLC, based on Form 13F filings with the SEC.

Stay updated on Frazier Management LLC with notifications on news.